Solace Therapeutics, Inc. Release: Abstract Presentations Address Key Clinical Questions Regarding The Vesair Bladder Control System For The Treatment For Stress Urinary Incontinence (SUI)

FRAMINGHAM, Mass.--(BUSINESS WIRE)--Solace Therapeutics, Inc., today announced data collected from the Company’s first two randomized controlled clinical trials will be presented at upcoming urological society meetings. Key clinical questions regarding long-term implantation and safety of the Vesair Bladder Control Balloon as well as the theory behind the use of air attenuation to reduce urine leakage during times of physical stress will be addressed.

Help employers find you! Check out all the jobs and post your resume.